After Hours
$
1.96
Change
+0.02 +1.03%
Volume
Volume 169,916
Jan 27, 2023, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 1.75
$ 1.94
Change
+0.19 +10.86%
Day low
Day high
$1.72
$1.98

52 week low
52 week high
$1.45
$6.38

Market cap
$3.39B
Average volume
23.23M
P/E ratio
N/A
Rev. per Employee
$823,580
EPS
-2.18
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on DNA
-
Dow Climbs Ahead in Whipsaw Trading
- Barron's Online
-
The Next Amazon? 12 Battered Stocks That Are Worth a Look.
- Barron's Online
-
DocuSign Stock Is Rising. Cathie Wood's ARK Bought Friday's Flop.
- Barron's Online
-
Ginkgo Bioworks started at outperform with $14.50 stock price target at Raymond James
- Tomi Kilgore
-
Ginkgo Bioworks Stock Sinks on Short Seller Report
- Barron's Online
-
Ginkgo Bio, SPACs' Next Big Thing, Gets Cool Investor Response
- Barron's Online
-
It's Now a Buyer's Market for SPACs as Deal Terms Get Sweetened
- Barron's Online
-
Bill Ackman's SPAC Now Trades at a Discount
- Barron's Online
-
Shares of Synthetic Biology Hopeful Zymergen Plunge as CEO Departs
- Barron's Online
-
Ginkgo Bioworks to go public through merger with SPAC Soaring Eagle in a deal valued at $15 bln
- Tomi Kilgore
Other News on DNA
-
Ginkgo Bioworks: Strange Equity Offering
- Seeking Alpha
-
Ginkgo Bioworks falls over 5% postmarket on $100M stock offering
- Seeking Alpha
-
10-Q: GINKGO BIOWORKS HOLDINGS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Ginkgo Bioworks Holdings Q3 2022 Earnings Preview
- Seeking Alpha
-
Notable earnings after Monday's close
- Seeking Alpha
-
Warning: DNA is at high risk of performing badly
- Seeking Alpha
-
Tracking Baillie Gifford's 13F Portfolio - Q3 2022 Update
- Seeking Alpha
-
Ginkgo Bioworks completes acquisition of Zymergen
- Seeking Alpha
-
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update
- Seeking Alpha
-
Ginkgo, Draper develop new technologies to detect engineered DNA
- Seeking Alpha
-
Warning: DNA is at high risk of performing badly
- Seeking Alpha
-
Ginkgo, Merck team up to improve pharma manufacturing process
- Seeking Alpha
- Loading more headlines...
Press Releases on DNA
-
Ginkgo Bioworks Provides Compensation Information Related to Recent Acquisitions
- PR Newswire - PRF
-
Ginkgo Announces Public Offering of Class A Common Stock
- PR Newswire - PRF
-
Ginkgo Bioworks Announces Proposed Public Offering of Class A Common Stock
- PR Newswire - PRF
-
Ginkgo Bioworks Reports Third Quarter 2022 Financial Results
- PR Newswire - PRF
-
Ginkgo Bioworks Announces Date of Third Quarter 2022 Results Presentation
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com